Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Prevalence, treatment and determinants of Obstructive Sleep Apnea and its symptoms in a population-based French cohort

Pauline Balagny, Emmanuelle Vidal-Petiot, Adeline Renuy, Joane Matta, Justine Frija-Masson, Philippe Gabriel Steg, Marcel Goldberg, Marie Zins, Marie-Pia d'Ortho, Emmanuel Wiernik
ERJ Open Research 2023; DOI: 10.1183/23120541.00053-2023
Pauline Balagny
1Université Paris-Cité, UFR de Médecine, Paris, France
2Service de Physiologie Explorations Fonctionnelles, APHP, Hôpital Bichat, AP-HP, Paris, France
3Université Paris Cité, Population-based Cohorts Unit, INSERM, Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, UMS 011, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pauline.balagny@aphp.fr
Emmanuelle Vidal-Petiot
1Université Paris-Cité, UFR de Médecine, Paris, France
2Service de Physiologie Explorations Fonctionnelles, APHP, Hôpital Bichat, AP-HP, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adeline Renuy
3Université Paris Cité, Population-based Cohorts Unit, INSERM, Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, UMS 011, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joane Matta
3Université Paris Cité, Population-based Cohorts Unit, INSERM, Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, UMS 011, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justine Frija-Masson
1Université Paris-Cité, UFR de Médecine, Paris, France
2Service de Physiologie Explorations Fonctionnelles, APHP, Hôpital Bichat, AP-HP, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Justine Frija-Masson
Philippe Gabriel Steg
1Université Paris-Cité, UFR de Médecine, Paris, France
4Département de Cardiologie, APHP, Hôpital Bichat, AP-HP, Paris, France
5INSERM U1148, Laboratory for Vascular Translational Science, Paris, France
6Institut Universitaire de France, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel Goldberg
3Université Paris Cité, Population-based Cohorts Unit, INSERM, Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, UMS 011, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcel Goldberg
Marie Zins
1Université Paris-Cité, UFR de Médecine, Paris, France
3Université Paris Cité, Population-based Cohorts Unit, INSERM, Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, UMS 011, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marie Zins
Marie-Pia d'Ortho
1Université Paris-Cité, UFR de Médecine, Paris, France
2Service de Physiologie Explorations Fonctionnelles, APHP, Hôpital Bichat, AP-HP, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel Wiernik
3Université Paris Cité, Population-based Cohorts Unit, INSERM, Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, UMS 011, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background Obstructive Sleep Apnea (OSA) is associated with increased morbidity and mortality. Although the disorder has been well-studied in selected high-risk populations, few data exist on its prevalence in the general population. We aimed to assessed the prevalence and determinants of OSA in France.

Methods Data from participants of the French population-based CONSTANCES cohort, aged 18–69 years at inclusion and being treated for sleep apnea or screened for OSA in 2017 using the Berlin questionnaire were analyzed. Weighted analyses were performed to provide recent and representative results in the general population.

Results Among 20 151 participants, the prevalence of treated OSA was 3.5% [3.0;3.9]. The prevalence of untreated subjects with a positive Berlin questionnaire was 18.1% [17.3;19.2] for a total weighted prevalence of OSA or high-risk of OSA of 20.9% [20.0;21.9]. Regarding prevalence of OSA symptoms, it was 37.2% [36.1;38.3] for severe snoring and 14.6% [13.8;15.5] for hypersomnolence. In multivariable logistic regression analysis, male sex, age, previous cardiovascular events, smoking, low educational level, low physical activity and depressive symptoms were associated with having either treated OSA or a positive Berlin questionnaire.

Conclusion In this large French population-based cohort, one in five participants had a high likelihood of OSA, whereas only 3.5% were treated for the disorder, suggesting major underdiagnosis in the general population. OSA diagnosis should be considered more often in people with risk factors such as depressive symptoms as well as unhealthy behaviors and socioeconomic conditions.

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflicts of interest: P. Balagny has received payment for presentation from Resmed.

Conflicts of interest: E. Vidal-Petiot has received honoraria for lecture from Servier and support for attending meeting from Servier

Conflicts of interest: A. Renuy declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Conflicts of interest: J. Matta declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Conflicts of interest: J. Frija-Masson has received research grants from LVL medical, support for attending meeting from LVL medical, VItalaire, ADEP assistance and SOS oxygène and fiduciary role in Digital Medical Hub SAS.

Conflicts of interest: P.G. Steg has received grants from Amarin, AstraZeneca, Bayer, Sanofi and Servier, consulting fees from Amgen, AstraZeneca, BMS/Myokarddia, Merck, Novo-Nordisk and Regeneron, Steering Comitee or Critical Event Committee from Amarin, AstraZeneca, Bayer, Boerhriger Ingelheim, Bristo-Myers Squibb, Idorsia, Novartis, PhaseBio, Pfizer, Sanofi and Servier, payments for lectures from AstraZeneca, Novartis and Novo-Nordisk, support for attending meetings from AstraZeneca and participation on a Data Safety Monitoring Board or Advisory Board from Servier, Sanofi, PHRI and Monash University.

Conflicts of interest: M. Goldberg declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Conflicts of interest: M. Zins declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Conflicts of interest: M.P.d'Ortho has received research grants from Sunrise medical, Desitin, ResMed, Lowenstein and Philips, honoraria for lecture from ResMed, Bioprojet, LVL medical, Viatalaire and Jazz Pharmaceuticals, payment for educational events from Jazz pharmaceutical and support for attending meeting from Bioprojet and Jazz pharmaceuticals.

Conflicts of interest: E. Wiernik declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Copyright ©The authors 2023
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

PreviousNext
Back to top
Vol 9 Issue 6 Table of Contents
ERJ Open Research: 9 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence, treatment and determinants of Obstructive Sleep Apnea and its symptoms in a population-based French cohort
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Prevalence, treatment and determinants of Obstructive Sleep Apnea and its symptoms in a population-based French cohort
Pauline Balagny, Emmanuelle Vidal-Petiot, Adeline Renuy, Joane Matta, Justine Frija-Masson, Philippe Gabriel Steg, Marcel Goldberg, Marie Zins, Marie-Pia d'Ortho, Emmanuel Wiernik
ERJ Open Research Jan 2023, 00053-2023; DOI: 10.1183/23120541.00053-2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prevalence, treatment and determinants of Obstructive Sleep Apnea and its symptoms in a population-based French cohort
Pauline Balagny, Emmanuelle Vidal-Petiot, Adeline Renuy, Joane Matta, Justine Frija-Masson, Philippe Gabriel Steg, Marcel Goldberg, Marie Zins, Marie-Pia d'Ortho, Emmanuel Wiernik
ERJ Open Research Jan 2023, 00053-2023; DOI: 10.1183/23120541.00053-2023
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Sleep medicine
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Mechanical assisted cough strategies - user perspectives and cough flows in children with neurodisability
  • Two is better than one: The double diffusion technique in classifying heart failure
  • Safety, Feasibility and Effectiveness of the remotely delivered Pulmonary Hypertension And Home-Based (PHAHB) Physical Activity intervention
Show more Original research article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society